Low-dose-rate brachytherapy for prostate cancer stands the test of time - the Swiss experience

BJU Int. 2020 Jun;125(6):750-751. doi: 10.1111/bju.15070.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Brachytherapy*
  • Humans
  • Male
  • Prostatic Neoplasms*
  • Radiotherapy Dosage
  • Switzerland